Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA.
Division of Orthopaedic Surgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.
Ann Surg Oncol. 2022 Dec;29(13):8632-8638. doi: 10.1245/s10434-022-12351-0. Epub 2022 Aug 6.
Dermatofibrosarcoma protuberans (DFSP) is a locally aggressive tumor with a low rate of metastatic disease. Previous series have shown a superiority of Mohs micrographic surgery (MMS) compared with wide local excision (WLE). Likewise, there is paucity of data examining the long-term follow-up of patients.
The purpose of the current study was to examine the outcome of surgical treatment of primary DFSP of the trunk and extremities.
We reviewed 236 patients (115 females, 121 males, mean age 41 ± 15 years) undergoing MMS (n = 81, 34%) or WLE (n = 155, 66%) to treat a primary DFSP. Mean tumor size and follow-up was 4 ± 2 cm and 7 years, respectively. Final margins were negative in 230 (97%) patients.
There was no difference (p > 0.05) in patient age, sex, tumor size, negative margin excision, or history of a previous inadvertent excision between patients who underwent WLE and those undergoing MMS. There were two cases of local recurrence and two cases of metastasis, with no difference in the 5-year local recurrence-free survival (98% vs. 99%, p = 0.69) or metastatic-free survival (98% vs. 100%, p= 0.27) between WLE and MMS.
There was no difference in oncologic outcome comparing MMS with WLE for DFSP outside the head and neck. The goal of treatment for DFSP is to achieve a negative margin, regardless of surgical treatment modalities. A 'less is more' approach to follow-up can likely be taken for patients with completely resected DFSP in easy-to-examine anatomical areas. In these patients, no formal follow-up should be required.
隆突性皮肤纤维肉瘤(DFSP)是一种局部侵袭性肿瘤,转移性疾病的发生率较低。既往研究表明,Mohs 显微外科手术(MMS)优于广泛局部切除术(WLE)。同样,缺乏检查患者长期随访结果的数据。
本研究旨在检查躯干和四肢原发性 DFSP 手术治疗的结果。
我们回顾了 236 例(女性 115 例,男性 121 例,平均年龄 41±15 岁)接受 MMS(n=81,34%)或 WLE(n=155,66%)治疗原发性 DFSP 的患者。平均肿瘤大小和随访时间分别为 4±2cm 和 7 年。230 例(97%)患者的最终切缘为阴性。
WLE 组和 MMS 组患者的年龄、性别、肿瘤大小、阴性切缘切除、或既往意外切除史无差异(p>0.05)。有 2 例局部复发和 2 例转移,WLE 组和 MMS 组 5 年局部无复发生存率(98%vs.99%,p=0.69)和无转移生存率(98%vs.100%,p=0.27)无差异。
头颈部以外的 DFSP,MMS 与 WLE 的肿瘤学结果无差异。DFSP 的治疗目标是获得阴性切缘,无论手术治疗方式如何。对于在易于检查的解剖区域完全切除的 DFSP 患者,随访可采取“少即是多”的方法。在这些患者中,无需进行正式随访。